GERNER; Eugene W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for GERNER; Eugene W..The latest application filed is for "carcinoma diagnosis and treatment, based on odc1 genotype".

Company Profile

1.7.10

GERNER; Eugene W. - Tucson AZ
Gerner; Eugene W - Tucson AZ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Carcinoma Diagnosis And Treatment, Based On Odc1 Genotype App 20190038584 - GERNER; Eugene W. ; et al.	2019-02-07
Carcinoma diagnosis and treatment, based on ODC1 genotype Grant 9,937,141 - Gerner , et al. April 10, 2	2018-04-10
Carcinoma Diagnosis And Treatment, Based On Odc1 Genotype App 20160213634 - GERNER; Eugene W. ; et al.	2016-07-28
Carcinoma diagnosis and treatment, based on ODC1 genotype Grant 9,121,852 - Gerner , et al. September 1, 2	2015-09-01
Cancer Prevention And Treatment Methods Based On Dietary Polyamine Content App 20130217743 - Raj; Kavitha P. ; et al.	2013-08-22
Carcinoma Diagnosis And Treatment, Based On Odc1 Genotype App 20130164751 - GERNER; Eugene W. ; et al.	2013-06-27
Hyperthermic inducible expression vectors for gene therapy and methods of use thereof Grant 7,285,542 - Tsang , et al. October 23, 2	2007-10-23
Hyperthermic inducible expression vectors for gene therapy and methods of use thereof Grant 7,098,191 - Tsang , et al. August 29, 2	2006-08-29
Inducible expression vectors and methods of use thereof Grant 7,056,897 - Tsang , et al. June 6, 2	2006-06-06
Hyperthermic inducible expression vectors for gene therapy and methods of use thereof App 20060019381 - Tsang; Tom ; et al.	2006-01-26
Hyperthermic Inducible Expression Vectors For Gene Therapy And Methods Of Use Thereof App 20050164961 - Tsang, Tom ; et al.	2005-07-28
Alpha-difluoromethylornithine(DFMO) suppresses polyamine levels in the human prostate App 20040162353 - Meyskens, Frank L. JR. ; et al.	2004-08-19
Hyperthermic inducible expression vectors for gene therapy and methods of use thereof Grant 6,709,858 - Tsang , et al. March 23, 2	2004-03-23
Inducible expression vectors and methods of use thereof App 20030207832 - Tsang, Thomas Chun-Chang ; et al.	2003-11-06
Alpha-Difluoromethylornithine (DFMO) suppresses polyamine levels in the human prostate App 20020137797 - Meyskens, Frank L. JR. ; et al.	2002-09-26
DFMO and sulindac combination in cancer chemoprevention Grant 6,258,845 - Gerner , et al. July 10, 2	2001-07-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.